Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06274385 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery.

Study acronym: BET_RSE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 22, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description shortened, about 29 wordsv3
  2. Primary completion date: Jun 2024 to Jun 2025v2 Show 5 more changesShow less
    • Primary endpoints: 1 to 2
    • Study completion date: Jun 2024 to Aug 2025
    • Start date changed from estimate of Feb 2024 to Mar 6, 2024
    • Eligibility criteria shortened, about 28 words
    • Secondary endpoints: details revised at 1 of 1 entry
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Betalains have well-known antioxidant and anti-inflammatory properties. Recent investigations examining the effects of a betalain-rich concentrate (BRC) on exercise and recovery performance show promise of BRC as an ergogenic aid. To date, no study has examined the effects of a single dose of a BRC on supramaximal performance and recovery. Therefore, the purpose of this study is to examine the effects of an acute dose of BRC on repeated-sprint cycling performance and recovery.
Trial Details
NCT Number NCT06274385
Lead Sponsor Drexel University
Conditions
(from sponsor)		 Nutraceuticals
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov